NCT00190658View on ClinicalTrials.gov

Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

July 31, 2004

Study Completion Date

September 30, 2010

Conditions

Failure to Thrive

Interventions

DRUG

Somatropin (rDNA origin) for injection

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Philadelphia

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00190658 - Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome | Biotech Hunter | Biotech Hunter